Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.468
Delayed Data
As of Feb 24
 -0.0221 / -4.51%
Today’s Change
0.26
Today|||52-Week Range
1.51
-26.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash--32.9M5.5M7.2M
 
 
 
 
Short Term Investment Cash-19.5M23.8M-27.5M1.7M
 
 
 
 
 
Cash & Short Term Investments--32.9M5.5M7.2M
 
 
 
 
 
ReceivablesReceivables--1.2M816.5K3.7M
 
 
 
 
 
InventoriesInventories--2.2M932.4K652.9K
 
 
 
 
 
Current AssetsOther Current Assets--1.0M1.4M1.1M
 
 
 
 
Current Assets--37.3M8.6M12.6M
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross--3.6M4.1M3.9M
 
 
 
 
Depreciation---1.5M-1.6M-1.9M
 
 
 
 
Intangible Assets--136.9K180.8K186.2K
 
 
 
 
Other Assets--860.0K569.8K459.7K
 
 
 
 
Total Assets--40.3M11.9M15.0M
 
 
 
 
 
LiabilitiesAccounts Payable--2.4M1.5M1.8M
 
 
 
 
Short Term Debt--4.1M4.4M333.3K
 
 
 
 
Accrued Expenses1.3M3.6M2.3M2.2M
 
 
 
 
 
Other Current Liabilities--3.6M2.3M3.2M
 
 
 
 
Other Liabilities--11.3M9.1M6.2M
 
 
 
 
 
Total LiabilitiesLong Term Debt--23.6M29.5M60.7M
 
 
 
 
Other Liabilities--9.5M3.1M1.7M
 
 
 
 
Total Liabilities--44.3M41.7M68.8M
 
 
 
 
 
EquityMinority Interest0.000.000.00-855.00
 
 
Preferred Stock--8.004.000.00
 
 
 
Common Equity---4.0M-29.8M-54.3M
 
 
 
 
Total Shareholder Equity---4.0M-29.8M-54.3M
 
 
 
 
 
Share InformationCommon Shares Outstanding--135.9M150.2M155.6M
 
 
 
 
 
Addtl. Info.No data currently available for this section.